Xing M. Response to Letter to the Editor from Boucai and Tuttle: "BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer". J Clin Endocrinol Metab 2022 Mar 9. pii: 6545262. doi: 10.1210.
PMID: 35262688